| 1 |
Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med, 2004, 348 (16): 1546-1554.
|
| 2 |
李建红，曹超，柴艳芬. TOLL样受体4与脓毒症免疫抑制相关性的研究进展[J/CD]. 中华危重症医学杂志（电子版），2015，8(4):213-216.
|
| 3 |
Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans.Advances in the understanding of pathogenesis,cardiovascular dysfunction, and therapy[J]. Ann Intern Med, 1990, 113 (3): 227-242.
|
| 4 |
Ahluwalia N, Blacher J, Szabo de Edelenyi F, et al. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease[J]. Atherosclerosis, 2013, 228 (2): 478-484.
|
| 5 |
Maisel A, Hollander JE, Guss D, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath[J]. J Am Coll Cardiol, 2004, 44 (6): 1328-1333.
|
| 6 |
Simioniuc A, Carluccio E, Ghio S, et al. Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients[J]. Int J Cardiol, 2016 (224): 416-423.
|
| 7 |
De Geer L, Fredrikson M, Oscarsson A. Amino-terminal pro-brain natriuretic peptide as a predictor of outcome in patients admitted to intensive care. A prospective observational study[J]. Eur J Anaesthesiol, 2012, 29 (6): 275-279.
|
| 8 |
Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988, 332 (6159): 78-81.
|
| 9 |
Hall C. Essential biochemistry and physiology of (NT-pro)BNP[J]. Eur J Heart Fail, 2004, 6 (3): 257-260.
|
| 10 |
Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides,their receptors, and cyclic guanosine monophosphate-dependent signaling functions[J]. Endocr Rev, 2006, 27 (1): 47-72.
|
| 11 |
Panagopoulou V, Deftereos S, Kossyvakis C, et al. N-TproBNP:an important biomarker in cardiac diseases[J]. Curr Top Med Chem, 2013, 13 (2): 82-94.
|
| 12 |
Park HJ, Baek SH, Jang SW, et al. Direct comparison of B-type natriuretic peptide and N-terminal pro-BNP for assessment of cardiac function in a large population of symptomatic patients[J]. Int J Cardiol, 2010, 140 (3): 336-343.
|
| 13 |
Qian A, Zhang M, Zhao G. Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma[J]. Eur J Trauma Emerg Surg, 2015, 41 (1): 57-64.
|
| 14 |
Lin X, Jiang X, Cheng Q, et al. Changes of left ventricular systolic and diastolic function and the diagnostic value of B-type natriuretic peptide in patients with sepsis[J]. Zhonghua Yi Xue Za Zhi, 2014, 94 (11): 816-820.
|
| 15 |
Hartemink KJ, Twisk JW, Groeneveld AB. High circulating N-terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill[J]. J Crit Care, 2011, 26 (1): 108. e1-e8.
|
| 16 |
Parker MM, McCarthy KE, Ognibene FP, et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans[J]. Chest, 1990, 97 (1): 126-131.
|
| 17 |
Hayase N, Yamamoto M, Asada T, et al. Association of Heart Rate with N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients: A Prospective Observational Cohort Study[J]. Shock, 2016, 46 (6): 642-648.
|
| 18 |
Maeder M, Ammann P, Kiowski W, et al. B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction[J]. Eur J Heart Fail, 2005, 7 (7): 1164-1167.
|
| 19 |
Shor R, Rozenman Y, Bolshinsky A, et al. BNP in septic patients without systolic myocardial dysfunction[J]. Eur J Intern Med, 2006, 17 (8): 536-540.
|
| 20 |
Cruz DN, Bellomo R, Ronco C. Clinical effects of polymyxin B-immobilized fiber column in septic patients[J]. Contrib Nephrol, 2007 (156): 444-451.
|
| 21 |
Ogawa T, de Bold AJ. Brain natriuretic Peptide production and secretion in inflammation[J]. J Transplant, 2012 (2012): 962347.
|
| 22 |
Landesberg G, Levin PD, Gilon D, et al. Myocardial dysfunction in severe sepsis and septic shock: no correlation with inflammatory cytokines in real-life clinical setting[J]. Chest, 2015, 148 (1): 93-102.
|
| 23 |
Pirracchio R, Deye N, Lukaszewicz AC, et al. Impaired plasma B-type natriuretic peptide clearance in human septic shock[J]. Crit Care Med, 2008, 36 (9): 2542-2546.
|
| 24 |
Ogawa T, de Bold AJ. Uncoordinated regulation of atrial natriuretic factor and brain natriuretic peptide in lipopolysaccharide-treated rats[J]. Biomarkers, 2012, 17 (2): 140-149.
|
| 25 |
Valette X, Lemoine S, Allouche S, et al. Effect of lipopolysaccharide, cytokines,and catecholamines on brain natriuretic peptide release from human myocardium[J]. Acta Anaesthesiol Scand, 2012, 56 (7): 860-865.
|
| 26 |
Pulido JN, Afessa B, Masaki M, et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock[J]. Mayo Clin Proc, 2012, 87 (7): 620-628.
|
| 27 |
Wu JR, Chen IC, Dai ZK, et al. Early elevated B-Type natriuretic peptide levels are associated with cardiac dysfunction and poor clinical outcome in pediatric septic patients[J]. Acta Cardiol Sin, 2015, 31 (6): 485-493.
|
| 28 |
Post F, Weilemann LS, Messow CM, et al. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients[J]. Crit Care Med, 2008, 36 (11): 3030-3037.
|
| 29 |
Liu D, Wang B, Kang Y, et al. The study of pro-B-type natriuretic peptide in the evaluation of the cardiac function in patients with severe sepsis[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2013, 25 (10): 584-588.
|
| 30 |
Klouche K, Pommet S, Amigues L, et al. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality[J]. J Intensive Care Med, 2014, 29 (4): 229-237.
|
| 31 |
Wang P, Zhang L, Zhou G, et al. Value explore and correlation analysis on pulmonary artery pressure and brain natriuretic peptide predicting prognosis in septic shock patients[J]. Zhonghua Yi Xue Za Zhi, 2015, 95 (27): 2194-2197.
|
| 32 |
Lin CW, Zeng XL, Zhang JF, et al. Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years[J]. J Card Fail, 2014, 20 (3): 168-173.
|
| 33 |
Lin CW, Tang W, Wen F, et al. Diagnostic accuracy of NT-ProBNP for heart failure with sepsis in patients younger than 18 Years[J]. PLoS One, 2016, 11 (1): e0147930.
|
| 34 |
Kandil E, Burack J, Sawas A, et al. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock[J]. Arch Surg, 2008, 143 (3): 242-246.
|
| 35 |
Papanikolaou J, Makris D, Mpaka M, et al. New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients[J]. Crit Care, 2014, 18 (3): R94.
|
| 36 |
Zhao HY, Liu F, Lu J, et al. The prognostic value of N-terminal pro-B-type natriuretic peptide in patients with severe sepsis and septic shock[J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2011, 23 (8): 467-470.
|
| 37 |
Wang F, Wu Y, Tang L, et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis[J]. Crit Care, 2012, 16 (3): R74.
|
| 38 |
Wang J, Ji W, Xu Z, et al. Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis[J]. Exp Ther Med, 2016,11 (1): 154-156.
|
| 39 |
Zhang XH, Dong Y, Chen YD, et al. Serum N-terminal pro-brain natriuretic peptide level is a significant prognostic factor in patients with severe sepsis among Southwest Chinese population[J]. Eur Rev Med Pharmacol Sci, 2013, 17 (4): 517-521.
|
| 40 |
Guaricci AI, Santoro F, Paoletti Perini A, et al. Correlations between NT-proBNP,outcome and haemodynamics in patients with septic shock[J]. Acta Cardiol, 2015, 70 (5): 545-552.
|
| 41 |
McLean AS, Huang SJ, Hyams S, et al. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock[J]. Crit Care Med, 2007, 35 (4): 1019-1026.
|
| 42 |
Rudiger A, Gasser S, Fischler M, et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis,septic shock,and acute heart failure[J]. Crit Care Med, 2006, 34 (8): 2140-2144.
|
| 43 |
Ju MJ, Zhu DM, Tu GW, et al. Predictive value of N-terminal pro-brain natriuretic peptide in combination with the sequential organ failure assessment score in sepsis[J]. Chin Med J (Engl), 2012, 125 (11): 1893-1898.
|
| 44 |
Ryoo SM, Kim WY, Huh JW, et al. Prognostic value of B-type natriuretic peptide with the sequential organ failure assessment score in septic shock[J]. Am J Med Sci, 2015, 394 (4): 287-291.
|
| 45 |
Cheng H, Fan WZ, Wang SC, et al. N-terminal probrain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study[J]. J Crit Care, 2015, 30 (3): 654. e9-e14.
|
| 46 |
Yang H, Song Z, Jin H, et al. Protective effect of rh-BNP on intestinal injury in the canine models of sepsis[J]. Int Immunopharmacol, 2014, 19 (2): 262-266.
|